The UK’s clinicians need training in medical cannabis – here’s why
On 1st November 2018, the UK’s Home Secretary announced changes to the scheduling of cannabis under the Misuse of Drugs Act of 2001.
On 1st November 2018, the UK’s Home Secretary announced changes to the scheduling of cannabis under the Misuse of Drugs Act of 2001.
Following a consultation last year, the irrefutable support for medicinal cannabis expansion on the Isle of Man is spurring the government to improve access for patients on the island. We spoke to the Minister for Health and Social Care, David Ashford, about the issue.
As the UK Government tries desperately to salvage a shattered economy, an unlikely but profitable lifeline presents itself as the medical cannabis industry booms.
A number of mothers, each with a severely epileptic child, are today holding a vigil outside the offices of the Department of Health & Social Care, the London headquarters of NHSE, the Scottish Parliament, and the Welsh Assembly.
For thousands of years, cannabis has been grown for reasons other than drugs.
The attorney general of New Jersey announced on Tuesday that the state will immediately begin allowing patients to obtain medical marijuana recommendations remotely via telehealth services amid the coronavirus pandemic.
New Mexico’s medical cannabis patients are at risk of running out of medicine due to the effects of COVID-19 and statewide shutdowns, according to a recent report published by O’Donnell Economics.
Materia has now acquired the licensed medical cannabis distributor, Cannaktiv, and has officially entered the German medical cannabis market.
The Louisiana House of Representatives overwhelmingly approved bills on Friday to significantly expand the state’s medical cannabis program by bringing in patients with more conditions and allowing dispensaries to deliver marijuana products directly to those patients’ homes.
Despite a 2018 schedule change allowing prescribing of medical cannabis, patients are still faced with multiple barriers, including misinformation, stigma, and financial constraints, preventing access to potentially life-changing medicine.